Nuclear emergency drug developed with DRDO tech gets approval

A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India (DCGI), the defence ministry said on......

Dr Reddy's launches Covid drug 2-DG at Rs 990 per sachet

Drug major Dr Reddy's Laboratories on Monday announced the commercial launch of COVID-19 treatment drug, 2-deoxy-D-glucose (2-DG), at a maximum retail price of Rs 990 per sachet.   IMAGE:......

DRDO's Covid drug: Benefits. Concerns

Commercial launch and supply to major government and private hospitals is expected in mid-June.Sohini Das reports. IMAGE: Defence Minister Rajnath Singh, left, and Health Minister Harsh Vardhan......

DRDO fights Covid, without ignoring defence research

As remarkable as DRDO's contribution in containing and treating COVID-19 has been, its success over the last 15 months has been in its primary role of developing conventional defence equipment and......

Solar energy yet not commercially viable: Kakodkar

Nuclear energy will continue to be an inevitable option for India as other alternative renewable energy sources like solar will take few more years to establish as a commercially viable technology,......

How Americans benefit by bonding with India

The popular perception is that companies in India are taking jobs away from Americans but the numbers on the ground tell a different story. In the last five years alone, 90 Indian companies have......

India ready to invest in Russia's pharma sector

India Inc is ready to invest in Russia's pharmaceutical sector and the two governments are working on a joint document to this effect, Commerce and Industry Minister Anand Sharma has said. "They......

Kalam's 10-point vision for a competitive India

Inaugurating the Confederation of Indian Industry's Partnership Summit 2006 in Kolkata on Tuesday, President APJ Abdul Kalam emphasised the need for 'spiritual connectivity' in the 'dynamics of......